Table 3.
CON | EX-30 | EX-60 | p-value | |
---|---|---|---|---|
Triglycerides | ||||
Fasting (mg/dL) | 134.8 ± 66.2 | 135.5 ± 85.4 | 118.7 ± 68.3 | 0.15 |
Peak (mg/dL) | 302.0 ± 162.7 | 308.1 ± 173.6 | 233.9 ± 124.7 | 0.11 |
Time to peak (hours) | 4.9 ± 1.4 | 4.7 ± 1.3 | 3.5 ± 2.3 | 0.10 |
AUC-tot (mg/dL × 8 h) | 1870.3 ± 869.9 | 1818.5 ± 1037.3 | 1444.4 ± 800.6 | 0.08 |
AUC-inc (mg/dL × 8 h) | 721.0 ± 494.0 | 737.6 ± 478.3 | 516.6 ± 303.9 | 0.24 |
Insulin | ||||
Fasting (pg/mL) | 92.6 ± 37.6 | 80.6 ± 38.9 | 81.5 ± 30.4 | 0.47 |
Peak (pg/mL) | 351.3 ± 128.3 | 344.8 ± 149.1 | 317.3 ± 113.8 | 0.41 |
Time to peak (hours) | 1.2 ± 0.4 | 1.3 ± 0.5 | 1.2 ± 0.4 | 0.26 |
AUC-tot (pg/mL × 8 h) | 1434.2 ± 563.0 | 1330.4 ± 510.5 | 1434.9 ± 500.5 | 0.29 |
AUC-inc (pg/mL × 8 h) | 696.3 ± 467.0 | 685.9 ± 374.6 | 783.9 ± 438.8 | 0.63 |
Glucose | ||||
Fasting (mmol/L) | 5.21 ± 0.32 | 5.03 ± 0.32 | 4.86 ± 0.46 | 0.15 |
Peak (mmol/L) | 5.98 ± 0.74 | 6.15 ± 1.04 | 6.33 ± 1.13 | 0.74 |
Time to peak (hours) | 1.1 ± 0.7 | 2.1 ± 1.6 | 3.0 ± 1.2* | 0.001a |
AUC-tot (mmol/L × 8 h) | 40.43 ± 2.29 | 41.15 ± 3.50 | 41.31 ± 3.01 | 0.79 |
AUC-inc (mmol/L × 8 h) | −1.26 ± 2.55 | 1.22 ± 3.29 | 1.86 ± 5.32 | 0.18 |
The above table displays the fasting and postprandial data for triglycerides, insulin, and glucose for the CON, EX-30, and EX-60 trials. Data are presented as Mean ± SD
AUC-tot total area under the curve; AUC-inc incremental area under the curve
* Significantly different from CON (p < 0.05)
a Significant trial effect (one-way ANOVA)